Literature DB >> 23116581

Urethral cancer.

Petros D Grivas1, Matthew Davenport, James E Montie, L Priya Kunju, Felix Feng, Alon Z Weizer.   

Abstract

Urethral carcinoma is a rare tumor with predominantly poor survival. Both the disease and its treatment can affect both sexual and urinary function. The natural history of urethral carcinoma varies, therefore the appropriate application of surgery, radiation, and chemotherapy remain unknown. Management of this disease remains driven by individual clinician experience and data derived from small case series. This article discusses the histology and anatomy of the male and female urethra, as well as their natural history. In addition, the epidemiology, clinical presentation, diagnosis, staging, treatment, and future directions of management of cancer arising in the urethra are addressed.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23116581     DOI: 10.1016/j.hoc.2012.08.006

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  3 in total

1.  Carcinoma of the urethra.

Authors:  Miao Zhang; Adebowale J Adeniran; Raghunandan Vikram; Pheroze Tamboli; Curtis Pettaway; Jolanta Bondaruk; Jinsong Liu; Keith Baggerly; Bogdan Czerniak
Journal:  Hum Pathol       Date:  2017-08-18       Impact factor: 3.466

2.  Transurethral holmium laser vaporization to the urethral tumour through a ureteroscope.

Authors:  Aihua Li; Wei Fang; Xiaoming Zuo; Feng Zhang; Weiwu Li; Honghai Lu; Sikuan Liu; Hui Wang; Binghui Zhang
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

3.  Nanoparticle albumin-bound-Paclitaxel in the treatment of metastatic urethral adenocarcinoma: the significance of molecular profiling and targeted therapy.

Authors:  Yasmin M Abaza; Carlos Alemany
Journal:  Case Rep Urol       Date:  2014-08-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.